KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Intangibles (2018 - 2025)

Vir Biotechnology's Intangibles history spans 8 years, with the latest figure at $7.8 million for Q4 2025.

  • On a quarterly basis, Intangibles fell 3.33% to $7.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.8 million, a 3.33% decrease, with the full-year FY2025 number at $7.8 million, down 3.33% from a year prior.
  • Intangibles hit $7.8 million in Q4 2025 for Vir Biotechnology, down from $7.9 million in the prior quarter.
  • Over the last five years, Intangibles for VIR hit a ceiling of $33.7 million in Q1 2021 and a floor of $7.8 million in Q4 2025.
  • Historically, Intangibles has averaged $23.6 million across 5 years, with a median of $25.5 million in 2023.
  • Biggest five-year swings in Intangibles: surged 1419.14% in 2021 and later tumbled 64.07% in 2025.
  • Tracing VIR's Intangibles over 5 years: stood at $33.3 million in 2021, then decreased by 1.6% to $32.8 million in 2022, then plummeted by 31.11% to $22.6 million in 2023, then crashed by 64.02% to $8.1 million in 2024, then fell by 3.33% to $7.8 million in 2025.
  • Business Quant data shows Intangibles for VIR at $7.8 million in Q4 2025, $7.9 million in Q3 2025, and $8.0 million in Q2 2025.